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Abstract
We examined whether outcomes of care (amputation and hospitalisation) among
patients with diabetes and foot ulcer differ between those who received pre-ulcer care
from podiatrists and those who did not. Adult patients with diabetes and a diagnosis
of a diabetic foot ulcer were found in the MarketScan Databases, 2005–2008.
Multivariate Cox proportional hazard models estimated the hazard of amputation and
hospitalisation. Logistic regression estimated the likelihood of these events. Propensity
score weighting and regression adjustment were used to adjust for potentially different
characteristics of patients who did and did not receive podiatric care. The sample
included 27 545 patients aged greater than 65+ years (Medicare-eligible patients with
employer-sponsored supplemental insurance) and 20 208 patients aged lesser than 65
years (non-Medicare-eligible commercially insured patients). Care by podiatrists in
the year prior to a diabetic foot ulcer was associated with a lower hazard of lower
extremity amputation, major amputation and hospitalisations in both non-Medicare-
eligible commercially insured and Medicare-eligible patient populations. Systematic
differences between patients with diabetes and foot ulcer, receiving and not receiving
care from podiatrists were also observed; specifically, patients with diabetes receiving
care from podiatrists tend to be older and sicker.
Introduction
Foot ulcers are a serious complication in patients with dia-
betes, with up to a 25% lifetime risk of foot ulceration in
patients with diabetes (1). Foot ulcers result from degradation
in the integumentary, vascular and nervous systems that typ-
ically occur in patients with long-standing diabetes mellitus.
This environment permits acute or chronic repetitive trauma to
frequently go unrecognised by the patient. If ulcers fail to heal
and progress into deep infection or gangrene, amputation of
the lower extremity may ensue, resulting in a 6–22% cumu-
lative amputation rate for patients with ulcers (2). Most foot
†An earlier version of this manuscript was presented as a Late-Breaking
Abstract at the American Diabetes Association 70th Scientific Sessions,
June 2010, Orlando, FL.
complications leading to lower extremity amputations begin
as ulcerations (3,4); therefore, proper preventive foot care is
key to the management of diabetes (5). Even so, many patients
Key Messages
• foot ulcers are a serious complication in patients with
diabetes
• in a large sample of individuals with diabetes and foot
ulcer, those who received care from podiatrists before
the onset of a foot ulcer were less likely to have
amputation, major amputation and hospitalisation
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• podiatrists have been proposed to serve as gatekeepers
for the prevention and management of diabetes-related
foot complications
• patients with diabetes and foot ulcer receiving care from
podiatrists tend to be older and sicker
with diabetes still do not receive preventive foot care prior to
ulceration.
Multidisciplinary care has been described to reduce
diabetes-related ulcers and amputations (6) in a variety of
health care settings including managed care (7), veteran (8,9),
military (10) and Native American (11). As part of a team
approach, podiatrists have been proposed to serve as gatekeep-
ers for the prevention and management of diabetes-related
foot complications (12,13). A recent analysis of the 5% Medi-
care sample from 1991 to 2007 suggested visiting a podiatrist
as part of a lower extremity care team in the year prior to a
lower extremity complication was protective for undergoing
lower extremity amputation (14). Additionally, a retrospective
cohort study of 485 patients found that the referral of patients
with diabetes mellitus and risk factors for ulceration and limb
loss to specialty multidiscipline podiatric medical care may be
associated with lower rates of ulceration and major amputation
in some patients, thereby reducing health care costs (15).
Using a large retrospective database of patients with dia-
betes in the USA, this study assessed the association between
podiatric care in the prevention of adverse events (amputation,
major amputation and hospitalisation) related to foot ulcers.
Comparisons were made between patients with pre-ulcer podi-
atric visits and patients without pre-ulcer podiatric visits using
regression adjustment and propensity score weighting to con-
trol for potential differences between these groups of patients.
Methods
Patients were selected from the Truven Health MarketScan
Research Databases , which are constructed from fully adju-
dicated medical and outpatient prescription drug claims. The
Commercial Database represents the health care experience
of tens of millions of employees and their dependents
(annually), covered under a variety of employer-sponsored
health plans. The Medicare Supplemental and Coordination of
Benefits (COB) Database contains the health care experience
of individuals with Medicare supplemental insurance paid by
employers. Both the Medicare-covered portion of payment
(represented as Coordination of Benefits Amount) and the
employer-paid portion are included in this database. The med-
ical claims are linked to outpatient prescription drug claims
and person-level enrolment data through encrypted enrollee
identifiers. The MarketScan databases conform to the confi-
dentiality requirements of the Health Insurance Portability and
Accountability Act of 1996; thus, the study did not require
informed consent or Institutional Review Board approval.
Study population
Patients aged 18 years and older enrolled in the MarketScan
Commercial or Medicare databases during years 2005–2008
were selected to the study population if they had a diabetes
diagnosis according to ICD-9-CM codes appearing on at least
one inpatient claim or two outpatient claims separated by at
least 30 days (codes are available in Table A1). Claims for
procedures that are diagnostic in nature (e.g. laboratory tests)
were not used to establish the diabetes diagnosis.
The index date for the analysis was assigned as the date of
the first observed visit with a diagnosis code indicating foot
ulcer in 2005–2008. Patients with an index date in 2005 were
excluded if they had any previous claims with a diagnosis of
foot ulcer in the previous year. All patients were required to
have at least 1 year of enrolment prior to the index date.
Patients switching health plans within the same employer
could be followed as they changed plans, and all patients were
followed through to their end of enrolment in any health plan
offered by the employer or up until 2009, whichever was later.
Patients were grouped into case (podiatry care) or com-
parison (no podiatry care) if the patient received care from
a podiatrist during the year prior to the index diabetic foot
ulcer diagnosis. The primary analyses compared patients with-
out any visits to a podiatrist during the year prior to the index
date (comparison) with those having one or more visits (case).
An examination was conducted of patients who had three or
more visits to a podiatrist prior to the index date (case) and
compared their outcomes to patients without any podiatric
visits. Because provider specialty code was used to identify
podiatry visits, patients were excluded from the comparison
cohort (no podiatric care) if provider specialty codes were not
available.
Patients with any lower extremity amputation in the year
prior to the index date were excluded from the study, based on
both procedure (defined below) and diagnosis codes. Patients
were also excluded from the case cohort if the claim for the
initial podiatric visit indicated a foot ulcer. Thus, the study
captured new episodes of care for a diabetic foot ulcer and
compared outcomes for patients who received care from a
podiatrist prior to the index foot ulcer to patients who did not
receive care from a podiatrist prior to the index foot ulcer.
Outcome variables
Three outcomes were measured: lower extremity amputation,
major amputation and hospitalisation. Lower extremity ampu-
tation was identified using procedure codes on the claims.
A subset of lower extremity amputations were classified as
major amputations, defined as amputations occurring at the
knee or higher. Inpatient hospitalisation was indicated by a
stay in an inpatient facility including at least one night of
room and board. A flag was created to indicate the presence
of each outcome during a fixed 24-month follow-up period
after the index date for patients who could be followed for
at least 24 months. Among patients with each outcome, time
in days from index (first observed foot ulcer) to the outcome
was measured.
Explanatory variables
Sociodemographic characteristics, plan type, health status
and risk factors were also measured. These characteristics
© 2013 The Authors
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included: patient age at index; gender; urban residence
(defined as residence in a metropolitan statistical area); and
whether the primary beneficiary was paid salaried or hourly
and US census region (Northeast, North Central, West and
South). Two measures were taken from the 2000 census data:
median household income by ZIP code of residence as a proxy
for income, and percent of college graduates (among residents
aged 25 and older) by ZIP as a proxy for education. Plan
types included comprehensive, health maintenance organisa-
tion (HMO), point-of-service (POS), preferred provider organ-
isation (PPO) and others (e.g. consumer-directed health plan
(CDHP) and capitated POS).
Health status variables were measured during the year
prior to index. The Charlson comorbidity index (CCI) is an
aggregate measure based on diagnoses associated with 19
conditions (16); however, because the CCI does not capture
mental health conditions, the number of Psychiatric Diag-
nostic Groupings (PDGs) was also included. The 12 PDGs
include mental health conditions such as alcohol-use disorders,
depression and schizophrenia (17). Refill adherence to antidia-
betic medications, as indicated by the percent of days covered
with antidiabetic medications on hand, was also captured.
Two sets of risk factors were included in the models and
also measured during the year prior to the index foot ulcer
diagnosis. Patient-level risk factors included cardiovascular
disease, nephropathy and diabetes-related eye disease. Foot-
level risk factors included neuropathy, peripheral arterial
disease, callus and others (e.g. abrasions) (18). Codes for these
conditions are detailed in Table A1.
Propensity score weighting
As patients in the case and comparison groups may be
different in terms of demographic characteristics or health
status, propensity score weighting was used to adjust for
observable differences between the two cohorts in two steps.
First, the probability of seeing a podiatrist was estimated
using a logistic regression (dependent variable = 1 if case and
0 if comparison), as a function of the explanatory variables.
Two other variables were added to the propensity score
models: the number of months a patient was followed over
time (enrolment months) and the percent of enrolment within
the patient’s employer × health plan using podiatric services
(to account for differences in podiatry benefits). Second,
cases were assigned a weight of 1 and comparison patients
were assigned a weight of p/(1 − p), where p is the predicted
probability of being a case from the logistic regression (19).
With this weighting, estimates are interpreted as the effect of
the treatment (care by a podiatrist) on the treated (those who
received care from a podiatrist) (20).
Separate propensity score regressions and weights were cal-
culated for each sample (commercial and Medicare-eligible)
and also for each analysis (i.e. main analysis where podiatry
care is defined as one or more pre-ulcer visits and the sen-
sitivity analysis that defined podiatry care as three or more
pre-ulcer podiatry visits).
Statistical analysis
Two sets of statistical models were estimated. First, Cox
proportional hazard models estimated the risk of amputation
at time t , conditional on survival (i.e. enrolment) to that
time (t), controlling for the explanatory variables. Second,
the likelihood of each outcome within a fixed length of
follow-up, 2 years after diagnosis of foot ulcer, was estimated
using logistic regression and the same covariates as the Cox
proportional hazard models, with the addition of the year
of the index date. Then, the predicted probability of each
outcome was estimated (21). Each of these analyses was
conducted with and without propensity score weights within
the commercial and Medicare-eligible samples.
Results
We found 20 208 commercially insured patients (7597 with
podiatrist care and 12 611 with no podiatrist care) and 27 545
Medicare-eligible patients (13 692 with podiatrist care and
13 853 with no podiatrist care) meeting all inclusion and
exclusion criteria, where podiatrist care was defined as one or
more visits to a podiatrist during the year prior to the index
foot ulcer (Table 1).
In both the commercial and Medicare samples, patients
receiving care from podiatrists were older than patients who
did not receive pre-ulcer podiatry care (Table 1). Also, a
higher percentage of patients receiving care from podiatrists
were females (P < 0·001). Patients receiving care from podi-
atrists were more likely to reside in an urban area than those
who did not receive care from podiatrists (P < 0·001).
Health status, as indicated by average scores on the CCI and
the number of PDGs, was lower and statistically significant
(P < 0·001) for patients receiving care from podiatrists, except
that differences in PDGs did not reach statistical significance
in the commercial sample (P = 0·212). A greater proportion
of patients receiving care from podiatrists had higher values
of patient-level and foot-level risk factors measured (all
P < 0·01) with the exception of nephropathy rates in the
Medicare sample where rates did not differ. Adherence to
antidiabetic medications, as indicated by a higher medication
possession ratio, was greater in patients receiving care from
podiatrists (P < 0·001).
In both the commercial and Medicare samples, patients
receiving care from podiatrists had a longer length of time to
amputation than those who did not receive such care (Table 1),
without adjusting for differences between patients who did and
did not receive pre-ulcer podiatric care. The difference was
about 55 (Medicare) to 77 (commercial) days longer until
amputation for podiatry patients (both P < 0·001). Results
were similar for major amputation, except that differences
in the time to amputation were not statistically significant
in the commercial sample. Patients seen by a podiatrist also
had a longer time to hospitalisation of 35 (Medicare) to 64
(commercial) days (all P < 0·001).
About 40% of enrollees could be followed over 24 months.
The percent of patients with each of the events (amputation or
hospitalisation) within 24 months was significantly lower for
patients in the podiatry care group for both the commercial
and Medicare samples (all P < 0·05).
© 2013 The Authors
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Table 1 Comparison of patients with diabetes and foot ulcer (unmatched comparison)*
Commercial Medicare
Characteristic
Podiatrist visit
(case)†
No podiatrist visit
(comparison) P-value
Podiatrist
visit (case)
No podiatrist
visit (comparison) P-value
n 7597 12 611 13 692 13 853
Age group, %
18–34 1·5 2·3 <0·001
35–44 6·0 9·7 <0·001
45–54 30·7 33·1 <0·001
55–64 61·8 54·8 <0·001
65–74 35·8 41·6 <0·001
75–84 46·8 44·0 <0·001
>85 17·4 14·4 <0·001
Age, years (mean ± SD) 55·0 ± 6·8 53·7 ±7·6 <0·001 77·6 ±6·9 76·7 ±6·9 <0·001
Female 44·7 38·1 <0·001 48·5 44·4 <0·001
Employee 66·6 68·0 0·037 81·0 81·3 0·565
Insurance plan type, %
Comprehensive 10·9 9·1 <0·001 56·1 45·8 <0·001
HMO 14·8 21·4 <0·001 7·5 16·7 <0·001
POS/EPO 11·3 8·8 <0·001 1·7 1·1 <0·001
PPO 58·5 56·6 0·009 33·5 34·9 0·014
Other 4·5 4·0 0·093 1·2 1·6 0·003
Urban residence 84·5 80·1 <0·001 86·7 82·4 <0·001
Geographic region, %
Northeast 16·1 8·9 <0·001 12·5 7·9 <0·001
North Central 31·5 27·5 <0·001 45·0 38·2 <0·001
South 42·4 47·5 <0·001 26·9 32·7 <0·001
West 9·7 15·8 <0·001 15·4 21·0 <0·001
Unknown 0·4 0·3 0·208 0·2 0·2 0·860
Median household income in ZIP, $ (mean ± SD) 45 588 ± 15 579 43 459 ± 14 565 <0·001 45 869 ± 15 403 44 345 ± 14 888 <0·001
Percent college graduates in ZIP (mean ± SD) 0·22 ± 0·13 0·21 ± 0·13 <0·001 0·23 ± 0·13 0·22 ± 0·13 <0·001
Health status‡
Charlson comorbidity index 2·64 ± 1·74 2·15 ± 1·74 <0·001 3·17 ± 1·99 2·82 ± 1·92 <0·001
Psychiatric diagnosis groups 0·18 ± 0·52 0·17 ± 0·52 0·212 0·19 ± 0·54 0·17 ± 0·50 <0·001
Medication possession ratio 0·64 ± 0·36 0·57 ± 0·38 <0·001 0·65 ± 0·36 0·63 ± 0·37 <0·001
Patient-level risk factors‡, %
Cardiovascular 61·2 56·6 <0·001 72·1 68·4 <0·001
Nephropathy 16·1 15·0 0·048 20·5 21·3 0·109
Eye 19·3 15·2 <0·001 13·6 11·3 <0·001
Foot-level risk factors‡, %
Neuropathy 15·0 6·8 <0·001 8·2 5·0 <0·001
Peripheral arterial disease 20·2 17·7 <0·001 32·5 26·6 <0·001
Callus 2·6 1·3 <0·001 3·7 1·3 <0·001
Months of enrolment after index 23·22 ± 15·04 21·85 ± 14·93 <0·001 23·26 ± 15·50 21·24 ± 15·24 <0·001
Year of index date, %
2005 24·1 23·6 0·418 24·25 28·28 <0·001
2006 23·8 21·9 0·002 26·79 23·92 <0·001
2007 25·3 25·3 0·925 24·81 23·86 0·068
2008 26·8 29·2 <0·001 24·15 23·94 0·675
Measures
n 7597 12 611 13 692 13 853
n with lower extremity amputation 811 1682 1042 1240
Time to amputation (days) 284·0 ± 347·8 207·4 ± 302·6 <0·001 265·2 ± 325·3 210·1 ± 298·0 <0·001
n with major amputation 179 380 280 407
Time to major amputation (days) 332·5 ± 280·2 271·0 ± 328·4 0·051 278·9 ± 312·3 215·5 ± 284·1 0·006
n with hospitalisation 3475 6451 8576 8592
Time to hospitalisation (days) 284·3 ± 320·1 220·5 ± 290·2 <0·001 288·4 ± 305·5 253·2 ± 291·5 <0·001
Measures (within 2 years)
n with 2-year follow-up 3304 4914 5990 5423
Lower extremity amputation, % 10·3 12·4 0·003 7·2 8·8 0·002
Major amputation, % 1·7 2·5 0·021 1·7 2·7 <0·001
Hospitalisation, % 44·2 51·6 <0·001 58·2 60·2 0·036
HMO, health maintenance organisation; POS, point-of-service; PPO, preferred provider organisation.
*Data source: 2004–2009 MarketScan Databases.
†Cases are patients with one or more visits to a podiatrist during the year prior to their index foot ulcer. Comparison patients did not have visits to a
podiatrist during the year prior to their index foot ulcer.
‡Measured 1 year prior to index date.
© 2013 The Authors
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After adjusting for covariates, patients receiving care from
podiatrists had lower rates of amputation, major amputa-
tion and hospitalisation than those who did not receive care
from podiatrists in all model specifications: the unweighted
and propensity score-weighted analyses for both the com-
mercial and Medicare samples (all P < 0·001) (Table 2).
For example, patients receiving care from podiatrists in the
commercial unweighted sample had a hazard of amputation
that was 25·2% lower than patients without podiatric care
[hazard ratio (HR) = 0·748, 95% confidence interval (CI):
0·686–0·816] and 20·6% lower for the Medicare unweighted
sample (HR = 0·794, 95% CI: 0·729–0·864). Results were
similar for the weighted samples. Commercial patients receiv-
ing pre-ulcer care from a podiatrist had a 25·0% lower hazard
of lower extremity amputation than patients without care from
a podiatrist in the commercial weighted sample – this was
23·4% for the Medicare weighted sample.
To assess whether a greater number of pre-ulcer podiatric
visits had a larger effect on the events, we conducted a sensi-
tivity analysis comparing patients with three or more pre-ulcer
podiatric visits to the comparison group without pre-ulcer
visits to a podiatrist. Hazard ratios estimated in the sensi-
tivity analysis were similar to the main analysis comparing
patients with one pre-ulcer podiatric visit to patients without
podiatric visits. Patients with three or more pre-ulcer podi-
atric visits in the weighted commercial sample had 23·7%
lower risk of lower extremity amputation (HR = 0·763, 95%
CI: 0·688–0·845) and a 25·7% lower hazard in the weighted
Medicare sample (HR = 0·743, 95% CI: 0·675–0·817) than
the comparison group (26·2% and 23·7% in the unweighted
commercial and Medicare samples, respectively).
Kaplan–Meier curves for lower extremity amputation are
shown in Figure 1 (weighted samples) and show that the
patients with a podiatrist visit had a longer time to amputation
than those without podiatry visits for both the commercial
(Panel A) and Medicare (Panel B) samples.
For the sample of patients with at least 2 years of follow-up
after the index date, the likelihood of each event (amputation
or hospitalisation) occurring within 2 years of the index
date was significantly lower in patients receiving care from
podiatrists (all P < 0·01) in both the commercial and Medicare
propensity score-weighted samples (Figure 2). Similar results
were found in the unweighted samples (all P < 0·01, not
shown).
Discussion
Podiatrists are medical practitioners focusing on management
and treatment of the foot and are considered by many health
care professionals to be the primary source of specialised foot
care in the USA. The more recent practice model developed
by the medical community describes the podiatrist as a ‘Limb
Preservationist’ (13). This new model focuses not only on the
contribution of podiatrists but also on several members of an
interdisciplinary team that medically and surgically manages
complicated and complex diabetic foot disorders.
In this study of two large samples of individuals
with diabetes and foot ulcer (commercially insured and
Medicare-eligible), we found that those who received care Ta
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Figure 1 Kaplan–Meier curve for time to lower extremity amputation.
(A) Commercially insured patients (n = 7597 case, n = 12 611 compar-
ison). (B) Medicare-eligible patients (n = 13 692 case, n = 13 853 com-
parison). Data source: 2004–2009 MarketScan Databases. Estimates
are shown using propensity score weights to account for differences
between case and comparison patients. Podiatry care group had one
or more podiatry visits during the year prior to the index foot ulcer
diagnosis; the no podiatry group had no such visits.
from podiatrists before the onset of a foot ulcer were less
likely to have adverse events such as amputation, major
amputation and hospitalisation. We also found that there
were systematic differences between patients with diabetes
and foot ulcer receiving care from podiatrists and patients
with diabetes and foot ulcer who did not receive care from
podiatrists. Namely, patients with diabetes receiving care
from podiatrists tend to be older and sicker than those who
do not receive care from podiatrists. Adjusting for these
differences via regression adjustment or a combination of
propensity score weighting and regression adjustment yielded
similar results – a significant reduction in the likelihood of
and time to each of the adverse events.
Our findings are in agreement with results observed in
previous studies of podiatric care and lower extremity ampu-
tations. Sloan et al. assessed a 5% sample of Medicare claims
between 1991 and 2007 for patients with diabetes-related
lower extremity complications. The study authors concluded
that patients having received care from both a podiatrist
and a lower extremity care specialist for an ulceration were
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Figure 2 Predicted probability of outcome within 2 years, weighted
samples. Data source: 2004–2009 MarketScan Databases. All compar-
isons between podiatry care and no podiatry care were statistically
significant at P <0·01. Estimates are shown using propensity score
weights to account for differences between case and comparison
patients. Podiatry care group had one or more podiatry visits during
the year prior to the index foot ulcer diagnosis; the no podiatry group
had no such visits.
36% less likely to have had a lower extremity amputation
compared to those who had only seen another type of
physician (14). In the same study, those with care provided
by only a podiatrist were also less likely to have had a lower
extremity amputation (44% less likely) but this was not
statistically significant. This study shows a lower likelihood
of amputation after receipt of podiatric care, but we are
unable to distinguish patients who receive other specialised
lower extremity care from those who do not.
More recently, Carls et al. also examined the effects
of podiatric care in the treatment of diabetic foot ulcers,
including populations of commercially insured and Medicare
patients. This analysis observed that podiatric care was
associated with a 2·67 and 1·35 percentage point reduc-
tion in amputation rates in a commercially insured and
Medicare-eligible population, respectively (22).
Several other studies also address the value of podiatric
care. A study of 91 patients in Austria with recently healed
foot ulcers and diabetes found a significant reduction in the
amount of time to ulcer recurrence among patients randomised
to podiatrist care (HR: 0·52, 95% CI: 0·30–0·93) (23). A
second study analysed the experience of 530 patients in
Finland who were receiving antidiabetes medications, but
had no obvious need for a podiatrist. Half the sample was
randomised to receive podiatrist care and the other half
to receive written instructions (24). At the end of 1-year
follow-up, the prevalence of callosities in regions other
than the calcaneal region decreased, as did the diameter of
these callosities in patients receiving care from podiatrists.
Lavery et al. (7) reported that a team including podiatrists
implemented a foot risk-based disease management program
for diabetes foot care in a US-managed care program and
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after 2 years, there was a 47% reduction in amputations, 38%
reduction in hospital admissions and 70% reduction in skilled
nursing facility admissions.
There are potential limitations to this analysis. First, we
did not extract the specific features of care or other types
of providers involved in the ulcer care. We measured receipt
of care from podiatrists prior to the onset of a foot ulcer to
determine whether these process differences led to differences
in outcomes. The aim of this study was to measure podiatry
in terms of its educational and holistic benefits during
a subsequent ulceration, not to measure process of care
differences within the episode of care. This strategy is
supported in the literature as podiatry care in patients with
diabetes resulted in higher knowledge scores and higher self-
care scores at 1 year (24). This is also supported in this
study as patients seeing podiatrists were also more adherent to
medication use as indicated by significantly higher medication
possession ratios. Second, we focused our analysis on those
patients with foot ulcer who did not have an amputation or an
ulcer in the previous year, which may limit generalisability to
other patient populations. However, this also underscores the
magnitude of these findings as patients with a previous foot
ulcer tend to be sicker than patients without a history of foot
ulcer, an observation supported by the significant differences
in CCI between our case and comparison cohorts. Third, our
results are based on administrative claims data, and all the
limitations inherent in coding systems and data designed for
reimbursement apply to this study.
In summary, in a sample of patients with diabetes and foot
ulcer, we found that pre-ulcer care by a podiatrist appears to
be associated with lower rates of lower extremity amputation
and hospitalisation.
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APPENDIX
Table A1 Codes for patient-level and foot-level risk factors*
Category ICD-9 Description
Codes applied for patient-level risk factors
Cardiology 401.xx Essential hypertension
Cardiology 402.xx Hypertensive heart disease
Cardiology 403.xx Hypertensive renal disease
Cardiology 404.xx Hypertensive heart and renal
disease
Cardiology 405.xx Secondary hypertension
Cardiology 415.0x Coronary artery disease
Cardiology 414.00 Arteriosclerotic heart disease
Cardiology 428.0 Congestive heart failure
Cardiology 429.2 Arteriosclerotic cardiovascular
disease
Cardiology 429.9 Heart disease, unspecified
Eye 362.0x Retinopathy
Nephropathy 580.xx Acute glomerulonephritis
Nephropathy 581.xx Nephrotic syndrome
Nephropathy 582.xx Chronic glomerulonephritis
Nephropathy 583.xx Nephritis and nephropathy not
specified
Nephropathy 584.xx Acute renal failure
Nephropathy 585.xx Chronic renal failure
Nephropathy 586.xx Renal failure unspecified
Nephropathy 587.xx Renal sclerosis unspecified
Nephropathy 588.xx Disorders resulting from impaired
renal functioning
Nephropathy 589.xx Small kidney of unknown cause
Codes applied for foot-level risk factors
Callus 700 Corn, clavus, callus
Neuropathy 355.0 Peripheral neuritis/neuralgia, acute,
sciatic nerve
Neuropathy 355.2 Peripheral neuritis/neuralgia, acute,
femoral nerve
Neuropathy 355.3 Peripheral neuritis/neuralgia, acute,
lateral popliteal nerve
Table A1 Continued
Category ICD-9 Description
Neuropathy 355.4 Peripheral neuritis/neuralgia, acute, medial
popliteal nerve
Neuropathy 355.5 Peripheral neuritis/neuralgia, acute,
posterior tibial nerve
Neuropathy 355.6 Peripheral neuritis/neuralgia, acute, plantar
nerve
Neuropathy 355.7 Peripheral neuritis/neuralgia, acute, due to
infection
Neuropathy 355.79 Peripheral neuritis/neuralgia, acute,
saphenous nerve
Neuropathy 355.8 Peripheral neuritis/neuralgia, acute, lower
limb, polyneuritis
Neuropathy 357.2 Polyneuropathy in diabetes (always code
first the diabetes, 250.6X)
Neuropathy 357.4 Polyneuropathy in other diseases classified
elsewhere (code underlying disease first)
Neuropathy 713.5 Charcot
Neuropathy 782.0 Numbness
PAD 440.20 Arteriosclerosis/atherosclerosis,
unspecified
PAD 440.21 Arteriosclerosis/atherosclerosis with
intermittent claudication
PAD 440.22 Arteriosclerosis/atherosclerosis, with rest
pain
PAD 440.23 Arteriosclerosis/atherosclerosis with
ulceration (use additional code
707.10-707.9)
PAD 440.24 Arteriosclerosis/atherosclerosis, with
gangrene
PAD 440.4 Artery of the extremities, chronic total
occlusion
PAD 443.1 Buerger’s disease
PAD 443.81 Peripheral vascular disease of diabetes
(code underlying diabetes first 250.7X)
PAD 443.9 Peripheral vascular disease
PAD 451.0 Phlebitis, superficial
PAD 451.11 Phlebitis, femoral vein (deep) (superficial)
PAD 451.19 Phlebitis, other (femoropopliteal vein, tibial
vein, popliteal vein)
PAD 451.2 Phlebitis, unspecified
PAD 454.0 Varicose vein, with ulceration
PAD 454.1 Stasis dermatitis, with inflammation
PAD 454.2 Varicose vein, with ulceration and
inflammation
PAD 454.8 Varicose vein with other complications
(oedema, pain, swelling)
PAD 454.9 Varicose vein, asymptomatic
PAD 459.11 Postphlebitic syndrome with ulcer
PAD 459.12 Postphlebitic syndrome with inflammation
PAD 459.13 Postphlebitic syndrome with ulcer and
inflammation
PAD 459.81 Venous insufficiency (use additional code
for any associated ulcer 707.10-707.9)
PAD, peripheral artery disease.
*Other Codes: Diabetes: ICD-9-CM: 250.xx (exclude: 648.8x). Foot ulcer:
ICD-9-CM: 707.10, 707.12, 707.13, 707.14, 707.15. Lower extremity
amputation: ICD-9-CM: 84.11; CPT-4: 10180, 12020, 12021, 27880,
27881, 27882, 27884, 27886, 27888, 28116, 28126, 28153, 28160,
28800, 28805, 28810, 28820, 28825. Major amputation: CPT-4: 27880,
27881, 27882.
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